相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Evaluating the Polarization of Tumor-Associated Macrophages Into M1 and M2 Phenotypes in Human Cancer Tissue: Technicalities and Challenges in Routine Clinical Practice
Sharmilla Devi Jayasingam et al.
FRONTIERS IN ONCOLOGY (2020)
Peroxiredoxin 5 ameliorates obesity-induced non-alcoholic fatty liver disease through the regulation of oxidative stress and AMP-activated protein kinase signaling
Mi Hye Kim et al.
REDOX BIOLOGY (2020)
Peroxiredoxin 6 Confers Protection Against Nonalcoholic Fatty Liver Disease Through Maintaining Mitochondrial Function
Dong Hun Lee et al.
ANTIOXIDANTS & REDOX SIGNALING (2019)
Nrf2 Activation Promotes Lung Cancer Metastasis by Inhibiting the Degradation of Bach1
Luca Lignitto et al.
CELL (2019)
Peroxiredoxin 5 Inhibits Glutamate-Induced Neuronal Cell Death through the Regulation of Calcineurin-Dependent Mitochondrial Dynamics in HT22 Cells
Mi Hye Kim et al.
MOLECULAR AND CELLULAR BIOLOGY (2019)
Peroxiredoxin V (PrdxV) negatively regulates EGFR/Stat3-mediated fibrogenesis via a Cys48-dependent interaction between PrdxV and Stat3
Hoon-In Choi et al.
SCIENTIFIC REPORTS (2019)
Interplay Between Mitochondrial Peroxiredoxins and ROS in Cancer Development and Progression
Tayaba Ismail et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
FAM53A Affects Breast Cancer Cell Proliferation, Migration, and Invasion in a p53-Dependent Manner
Jie Zhang et al.
FRONTIERS IN ONCOLOGY (2019)
Nrf2 stabilization prevents critical oxidative damage in Down syndrome cells
Emiliano Zamponi et al.
AGING CELL (2018)
Upregulation of IL-11,an IL-6 Family Cytokine, Promotes Tumor Progression and Correlates with Poor Prognosis in Non-Small Cell Lung Cancer
Meng Zhao et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2018)
Peroxiredoxin 5 regulates adipogenesis-attenuating oxidative stress in obese mouse models induced by a high-fat diet
Mi Hye Kim et al.
FREE RADICAL BIOLOGY AND MEDICINE (2018)
Correlation of Cancer Stem-Cell Markers OCT4, SOX2, and NANOG with Clinicopathological Features and Prognosis in Operative Patients with Rectal Cancer
Liuping You et al.
YONSEI MEDICAL JOURNAL (2018)
IL-37 inhibits invasion and metastasis in non-small cell lung cancer by suppressing the IL-6/STAT3 signaling pathway
Mingfang Jiang et al.
THORACIC CANCER (2018)
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Freddie Bray et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2018)
Prognostic roles of mRNA expression o f peroxiredoxins in lung cancer
Liangyuan Chen et al.
ONCOTARGETS AND THERAPY (2018)
Myeloid HO-1 modulates macrophage polarization and protects against ischemia-reperfusion injury
Min Zhang et al.
JCI INSIGHT (2018)
Peroxiredoxin 5 overexpression enhances tumorigenicity and correlates with poor prognosis in gastric cancer
Bokyung Kim et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2017)
Targeting Immunotherapy to the Tumor Microenvironment
Michael Dougan et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2017)
MicroRNA-218 functions as a tumor suppressor in lung cancer by targeting IL-6/STAT3 and negatively correlates with poor prognosis
Yan Yang et al.
MOLECULAR CANCER (2017)
Mitochondrial ROS Production Protects the Intestine from Inflammation through Functional M2 Macrophage Polarization
Laura Formentini et al.
CELL REPORTS (2017)
Reprogramming of Tumor-Associated Macrophages with Anticancer Therapies: Radiotherapy versus Chemo- and immunotherapies
Geraldine Genard et al.
FRONTIERS IN IMMUNOLOGY (2017)
High systemic IL-6 is associated with worse prognosis in patients with non-small cell lung cancer
Estela Maria Silva et al.
PLOS ONE (2017)
Peroxiredoxin 5 promotes the epithelial-mesenchymal transition in colon cancer
Hye-Mi Ahn et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2017)
Tumor microenvironment and therapeutic response
Ting Wu et al.
CANCER LETTERS (2017)
The role of peroxiredoxins in cancer
Arianna Nicolussi et al.
MOLECULAR AND CLINICAL ONCOLOGY (2017)
Tumor-associated macrophages: Potential therapeutic targets for anti-cancer therapy
Yoshihiro Komohara et al.
ADVANCED DRUG DELIVERY REVIEWS (2016)
Peroxiredoxin 6 Is a Crucial Factor in the Initial Step of Mitochondrial Clearance and Is Upstream of the PINK1-Parkin Pathway
Shuaipeng Ma et al.
ANTIOXIDANTS & REDOX SIGNALING (2016)
Oxidative stress, polarization of macrophages and tumour angiogenesis: Efficacy of caffeic acid
Nada Orsolic et al.
CHEMICO-BIOLOGICAL INTERACTIONS (2016)
ROS-mediated endoplasmic reticulum stress and mitochondrial dysfunction underlie apoptosis induced by resveratrol and arsenic trioxide in A549 cells
Shiyan Gu et al.
CHEMICO-BIOLOGICAL INTERACTIONS (2016)
Peroxiredoxin 5 (Prx5) decreases LPS-induced microglial activation through regulation of Ca2+/calcineurin-Drp1-dependent mitochondrial fission
Junghyung Park et al.
FREE RADICAL BIOLOGY AND MEDICINE (2016)
Overview on Peroxiredoxin
Sue Goo Rhee
MOLECULES AND CELLS (2016)
Role of the tumor microenvironment in tumor progression and the clinical applications (Review)
Yao Yuan et al.
ONCOLOGY REPORTS (2016)
Peroxiredoxin 5 Protects TGF-βInduced Fibrosis by Inhibiting Stat3 Activation in Rat Kidney Interstitial Fibroblast Cells
Hoon-In Choi et al.
PLOS ONE (2016)
Promotion of p53 expression and reactive oxidative stress production is involved in zerumbone-induced cisplatin sensitization of non-small cell lung cancer cells
Zhenhong Hu et al.
BIOCHIMIE (2014)
Tumor-associated macrophage-derived IL-6 and IL-8 enhance invasive activity of LoVo cells induced by PRL-3 in a KCNN4 channel-dependent manner
Heyang Xu et al.
BMC CANCER (2014)
Tumor-Associated Macrophages: From Mechanisms to Therapy
Roy Noy et al.
IMMUNITY (2014)
Adoptive Transfer of Heme Oxygenase-1 (HO-1)-Modified Macrophages Rescues the Nuclear Factor Erythroid 2-Related Factor (Nrf2) Antiinflammatory Phenotype in Liver Ischemia/Reperfusion Injury
Jing Huang et al.
MOLECULAR MEDICINE (2014)
Antioxidants Accelerate Lung Cancer Progression in Mice
Volkan I. Sayin et al.
SCIENCE TRANSLATIONAL MEDICINE (2014)
ROS play a critical role in the differentiation of alternatively activated macrophages and the occurrence of tumor-associated macrophages
Yan Zhang et al.
CELL RESEARCH (2013)
Accelerated Development of Pulmonary Fibrosis via Cu, Zn-superoxide Dismutase-induced Alternative Activation of Macrophages
Chao He et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2013)
Ascorbic Acid and a Cytostatic Inhibitor of Glycolysis Synergistically Induce Apoptosis in Non-Small Cell Lung Cancer Cells
Saleha B. Vuyyuri et al.
PLOS ONE (2013)
Proteomic analysis of non-small cell lung cancer tissue interstitial fluids
Shaomin Li et al.
WORLD JOURNAL OF SURGICAL ONCOLOGY (2013)
Human peroxiredoxin 1 modulates TGF-β1-induced epithelial-mesenchymal transition through its peroxidase activity
Bin Ha et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2012)
Acquired cancer stem cell phenotypes through Oct4-mediated dedifferentiation
S. M. Kumar et al.
ONCOGENE (2012)
Downregulation of transcription factor SOX2 in cancer stem cells suppresses growth and metastasis of lung cancer
R. Xiang et al.
BRITISH JOURNAL OF CANCER (2011)
M2 Macrophages Induced by Prostaglandin E2 and IL-6 from Cervical Carcinoma Are Switched to Activated M1 Macrophages by CD4+ Th1 Cells
Moniek Heusinkveld et al.
JOURNAL OF IMMUNOLOGY (2011)
Epithelial to Mesenchymal Transition by TGFβ-1 Induction Increases Stemness Characteristics in Primary Non Small Cell Lung Cancer Cell Line
Giuseppe Pirozzi et al.
PLOS ONE (2011)
Quercetin Induces the Expression of Peroxiredoxins 3 and 5 via the Nrf2/NRF1 Transcription Pathway
Naoya Miyamoto et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2011)
The epithelial-mesenchymal transition generates cells with properties of stem cells
Sendurai A. Mani et al.
CELL (2008)
Stat3 mediates myeloid cell-dependent tumor angiogenesis in mice
Maciej Kujawski et al.
JOURNAL OF CLINICAL INVESTIGATION (2008)
Targeting the tumor microenvironment
Paraic A. Kenny et al.
FRONTIERS IN BIOSCIENCE-LANDMARK (2007)
Nrf2-Keap1 defines a physiologically important stress response mechanism
H Motohashi et al.
TRENDS IN MOLECULAR MEDICINE (2004)
Mutant K-rasV12 increases COX-2, peroxides and DNA damage in lung cells
A Maciag et al.
CARCINOGENESIS (2004)
Overexpression of peroxiredoxins I, II, III, V, and VI in malignant mesothelioma
VL Kinnula et al.
JOURNAL OF PATHOLOGY (2002)
M-1/M-2 macrophages and the Th1/Th2 paradigm
CD Mills et al.
JOURNAL OF IMMUNOLOGY (2000)